Table 2.
Baseline clinical and demographic characteristics of groups A and B.
| Baseline characteristics | Group A (Cyclosporine, reference group) | Group B (Azathioprine) | Mean/proportion difference | 95% CI of difference |
|---|---|---|---|---|
| Number of patients | 40 | 40 | ||
| Age (years) | 35.98 ± 9.36 | 36.68 ± 9.68 | −0.70 | −4.94 to 3.54 |
| Duration of illness (years) | 5.21 ± 4.87 | 6.56 ± 5.81 | −1.35 | −3.74 to 1.04 |
| Gender (Female: Male) | 24:16 | 24:16 | 0% | −20.58 to 20.58 |
| Angioedema | 20 (50) | 21 (52.5) | 2.5% | −18.57 to 23.26 |
| UAS7 | 28.70 ± 4.42 | 28.88 ± 4.25 | −0.18 | −2.11 to 1.76 |
| ASST (positive) | 16 (40) | 12 (30) | 10% | −10.6 to 29.48 |
| APST (positive) | 2 (5) | 2 (5) | 0% | −12.06 to 12.06 |
| Serum IgE levels median (IQR, IU/ml) | 91.35 (50.2–248.75) | 243 (78.27–654.0) | −105.15@ | −308.0 to −16.8 |
@: (Hodges – Lehman median difference).
IQR – Interquartile range.
ASST – Autologous serum skin test.
APST – Autologous plasma skin test.
UAS7- urticaria activity score over 7 days, ranges from 0 to 42.
CI – Confidence Interval.
Bold numerical values show significant CIs.